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Effects of bilirubin on transepithelial transport of sodium, water, and
urea. Urinary concentrating defects and renal salt wasting have been
described in the hyperbilirubinemic Gunn strain of rat. Homozygous
animals demonstrate significant reductions in renal medullary urea and
sodium ion concentrations. These observations are consistent with
possible bilirubin associated disorders in the transepithelial transport of
water and solute. To test this hypothesis, measurements of active
sodium transport and passive water and urea fluxes were made in
hemibladders isolated from the Dominican toad, Bufo marineis. Tissues
were exposed to amphibian bicarbonate Ringer's solution containing
0.1 mM bilirubin with 0.05% bovine serum albumin (BSA) or BSA
alone. Vasopressin-stimulated sodium transport, as reflected by short
circuit current (SCC), was inhibited by 18 6% in the presence of
bilirubin (N = 10; P < 0.02). Cyclic AMP (p-Cl-phenylthio cAMP l0-
M) stimulated SCC was inhibited to a similar degree in the presence of
bilirubin. The inhibition was noted only when bilirubin was in the
serosal bath, and it could be abolished with BSA 0.5%. Bilirubin had no
effect on the increase in SCC induced by higher concentrations of cyclic
AMP (I0- M), aldosterone, or amphotericin B. Furthermore, bilirubin
had no effect on the hydro-osmotic response to vasopressin and
vasopressin-induced changes in urea permeability. These findings show
that short-term exposure to bilirubin exerts a tissue-specific effect on
the vasopressin-stimulated active transport of sodium but has no effect
on the vasopressin-induced fluxes of water and urea.
Effets de Ia bilirubine sur le transport transépithélial de sodium, d'eau,
et d'urée. Des défauts de concentration urinaire et une fuite rénale de
sodium ont été observes dans Ia souche de rats hyperbilirubinémiques
Gunn. Les animaux homozygotes présentent une reduction significative
des concentrations en urée et en ion sodium dans la médullaire rénale.
Ces observations sont compatibles avec des désordres peut-étre lies a Ia
bilirubine du transport transepithélial d'eau et de solutés. Afin de tester
cette hypothèse, des mesures du transport actif du sodium et des flux
passifs d'eau et d'urée ont été effectuées dans des hémi-vessies isoldes
partir du Crapaud Dominicain Bufo marinus. Les tissus étaient
exposés a une solution de Ringer bicarbonate pour amphibiens conte-
nant 0,1 msi de bilirubine avec 0,05% de serum albumine de boeuf
(BSA) ou de Ia BSA seule. Le transport de sodium stimulé par Ia
vasopressine reflété par le courant de court circuit (SCC) était inhibé de
18 6% en presence de bilirubine (N = 10; P < 0,02). Le SCC stimulé
par I'AMP cyclique (p-Cl-phenylthio cAMP l0- M) était inhibé de
facon semblable en presence de bilirubine. L'inhibition était notde
uniquement quand la bilirubine était dans le ham séreux, et ne pouvait
ëtre abolie avec 0,5% de BSA. La bilirubine n'avait pas d'effet sur
l'augmentation de SCC induite par des concentrations plus élevées de
cAMP (l0 M), par l'aldostérone ou par l'amphotéricine B. De plus, Ia
bilirubine était sans effet sur la réponse hydro-osmotique a Ia vasopres-
sine, ni sur les modifications de Ia perméabilité a l'urée induite par Ia
vasopressine. Ces résultats montrent qu'une courte exposition a la
bilirubine exerce un effet spécifique de tissu sur le transport actif du
sodium stimulé par Ia vasopressine, mais est sans action sur les flux
induits par la vasopressine d'eau et d'urée.
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While the effects of hyperbilirubinemia on the central ner-
vous system remain paramount, the toxicity of this pigment has
been clearly demonstrated in other organs including the kidney
[1—4]. The Gunn strain of rat with congenital absence of hepatic
glucuronyl transferase and chronic unconjugated hyperbil-
irubinemia develops significant polyuria. When studied in
greater detail, these animals uniformly show a limited free
water clearance, increased fractional sodium excretion, and
deposits of crystalline bilirubin in the papilla of the kidney
[1—3]. In addition to its renal effects, high concentrations of
unconjugated bilirubin promote the secretion of water and
sodium in the isolated perfused intestine of the hamster [4].
Taken together, these data are consistent with the view that
bilirubin may alter the epithelial transport of solute and water.
Although the data gathered in the Gunn rat are highly
suggestive of altered renal epithelial transport, the effects of
bilirubin are less clear in the human infant. Broberger and
Aperia [5] demonstrated that hyperbilirubinemic newborns
given a salt and water load had a decreased glomerular filtration
rate (GFR) and a higher fractional sodium excretion than
nonhyperbilirubinemic control infants. However, Engle and
Arant [6] performed a similar clinical study on hyperbiliru-
binemic newborns and failed to show any significant differences
in GFR or in the tubular handling of sodium. These infants were
not challenged either with a salt or water load. If high concen-
trations of bilirubin change renal function in the newborn infant,
the alterations may be subtle and may depend on a more
prolonged exposure.
The urinary concentrating and diluting capabilities of the
kidney depend on the epithelial transport of solute and water.
Because evidence indicates that bilirubin may interfere with
this epithelial cell function, the present study was designed to
examine the effects of unconjugated bilirubin on transepithelial
transport of sodium, water, and urea. The toad urinary bladder
was chosen as the experimental model, for it is essentially a
single epithelial cell membrane which, in many respects, mim-
ics the distal nephron of the mammalian kidney. Under the
influence of vasopressin, it actively transports sodium and
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allows for the passive reabsorption of urea and water 171. Data
gathered from these studies show that stimulated sodium trans-
port may be affected by unconjugated bilirubin. The inhibition
of vasopressin-stimulated sodium transport by bilirubin was
seen in preparations derived from previously well-hydrated
animals in whom a salt-losing tendency would not be expected.
Methods
Dominican toads (Bufo marinus) were obtained from Na-
tional Reagents, Bridgeport, Connecticut, USA. All toads were
sacrificed by double pithing. Bladders were then removed and
used for selected experiments as outlined below. The bladders
were bathed in an amphibian Ringer's solution (sodium 114
mEq/liter, potassium 3.2 mEq/liter, bicarbonate 2.4 m, chlo-
ride 113.4 mEq/liter, calcium 0.89 mM) which has an osmolality
of 218 mOsmlkg water and a pH of 8.1. A concentration of 0.1
mM bilirubin (—5 mg/dl) was used for all experiments. The
bilirubin was initially dissolved in 0.1 N NaOH and then added
to the amphibian Ringer's solution, which was found to be the
maximum concentration of bilirubin that would consistently
stay in solution at this alkaline pH. Unless otherwise stated,
albumin 0.05% was present in both control and bilirubin-
containing solutions. The albumin had no effect on sodium
transport, water movement, or urea transport in preliminary
investigations, and it served to maintain the bilirubin's solubil-
ity in an otherwise supersaturated solution.
The cyclic AMP salt used was 8 (p-chlorophenylthio)-
adenosine 3'5' cyclic phosphate, monosodium dihydrate, ICN
Pharmaceuticals, Irvine, California, USA. Vasopressin was
obtained from Parke, Davis and Company, Detroit, Michigan,
USA. Isotopes were from New England Nuclear Corporation,
Boston, Massachusetts, USA. Aldosterone was from
Steraloids, Inc., Wilton, New Hampshire, USA. Bilirubin and
bovine serum albumin (BSA) were obtained from Sigma Chemi-
cal, St. Louis, Missouri, USA. Amphotericin B was from ER
Squibb, mc, Princeton, New Jersey, USA.
Because the toad urinary bladder is bibbed, hemibladders
from the same animal were used in control and experimental
preparations. Thus, all observations were paired and analyzed
statistically using Student's paired t test. Results were ex-
pressed as the mean the SE.
Determination of sodium transport
The measurement of sodium transport across the toad blad-
der was determined by the short circuit current (SCC) tech-
nique of Ussing and Zerahn 18]. Hemibladders were mounted
onto a lucite chamber (Nicholson Precision Instruments,
Gaithersburg, Maryland, USA). Both surfaces of the
hemibladder were bathed in the amphibian Ringer's solution
bubbled with compressed air. After 60 mm of equilibration,
both serosal and mucosal bathing solutions were changed.
Unless specifically mentioned, the mucosal bath consisted of
amphibian Ringer's solution while the serosal bath contained
Ringer's with albumin (control) or albumin and bilirubin (ex-
perimental). The lucite chambers were covered to prevent light
exposure. Tissues were then bathed in these solutions for 45
mm prior to the addition of any stimulatory test substance.
Short circuit current was recorded throughout the equilibration
period, the bilirubin exposure period, and the stimulation
period. Transepithelial potential difference (PD) was only re-
corded during the equilibration and bilirubin exposure periods.
In the initial series of experiments, the tissues were stimu-
lated with vasopressin (40 mU/ml) added to the serosal bath.
Since the peak response in SCC occurred within 30 mm and was
followed by a rapid return toward baseline, the vasopressin
stimulation period was limited to 60 mm. This procedure was
repeated with a number of variations which included increasing
the albumin in the serosal bath to 0.5% in control and experi-
mental situations, placing the bilirubin-albumin solutions on the
mucosal rather than the serosal side of the bladder, and
substituting cyclic AMP (p-chlorophenylthio cAMP) io- or
iO M for vasopressin.
Aldosterone (l0— M) was studied in the next series of SCC
experiments. To suppress endogenous aldosterone production,
toads were soaked in 0.6% saline for at least 48 hr prior to
sacrifice. Bladders were excised, mounted onto the chambers,
and left overnight bathed in a Ringer's solution containing
penicillin G 0.1 mg/ml, streptomycin 0.1 mg/mI, and glucose 10
mM to further deplete them of endogenous hormone. On the
morning of the experiment, the serosal and mucosal bathing
solutions were replaced with Ringer's solution which did not
contain antibiotics or glucose. Bladders were short-circuited to
test viability. Bathing solutions were again changed so that the
experimental tissues were exposed to bilirubin. Aldosterone
was then added to the serosal medium of both experimental and
control hemibladders and readings of SCC were made for 360
additional minutes.
In the third series of experiments, SCC was stimulated by the
antifungal agent amphotericin B (2.5 xg/ml) placed in the
mucosal bath of both experimental and control tissues. Blad-
ders were prepared as described in the initial vasopressin
experiments. SCC measurements were recorded for 90 mm
following the addition of amphotericin B to the mucosal solutions.
Considerable variation in the absolute value of SCC exists
between hemibladders. To standardize the experimental data
for comparison, SCC was expressed as a ratio reflecting the
change rather than the absolute value. This ratio was derived by
dividing the measured SCC at given time t by the measured
SCC obtained prior to the addition of any drug, to. Experimental
hemibladders were compared to matched controls using the
equation shown below:
SCC Exp
SCCto
SCC Control
SCC
Measurement of osmotic water movement
Osmotic water flow across the isolated toad urinary bladder
was determined gravimetrically using the Bentley bag technique
[9]. While electrical parameters were not measured, tissue
integrity was indirectly assessed by membrane impermeability
in the absence of hormone and maximal water flow in the
presence of hormone. The paired hemibladders were dissected
out and each hemibladder was tied to a short glass tube forming
a bag. The hemibladder bags were rinsed twice and then filled
with 5 ml of deionized water. Each bladder was suspended in 50
ml of amphibian Ringer's solution containing 0.05% albumin.
(1)
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The experimental Ringer's solution also contained bilirubin.
Hemibladders were removed from the bath, gently blotted on
filter paper, and weighed on a balance (Mettler H-35 AR,
Mettler Instrument Corporation, Hightstown, New Jersey,
USA) to determine weight loss as a measure of water flow.
After a control period of 45 mm, bladders were exposed to
vasopressin 20 mU/mI and weights were measured at 15-mm
intervals for 60 mm. In selected experiments, the hydro-
osmotic response was induced with vasopressin 1 mU/ml or
cyclic AMP placed in the serosal bathing medium in a concen-
tration of iO M. Again, all experiments were performed in a
darkened room with the individual beakers wrapped with
aluminum foil to minimize exposure to light.
Measurement of urea permeability
Urea permeability was assessed by the method of Maffly et al
U0]. Hemibladders were mounted onto lucite chambers and
short-circuited in a similar fashion to that described in the SCC
studies. To prevent bacterial breakdown of urea, the Ringer's
solution contained penicillin G, 0.1 mg/mi, and streptomycin,
0.1 mg/ml. The presence of antibiotics in the bathing solution
had no demonstrable effect on either basal or vasopressin-
stimulated urea fluxes (basal with antibiotics 16.5 4.2 x l0—
cm2 sec, basal without antibiotics 16.8 4.9 x l0 cm2 sec,
N = 4; and VP stimulated with antibiotics 109 8.4 x l0—
cm2 sec, VP stimulated without antibiotics 105 1.4 x l0
cm2 sec, N = 8). '4C-labeled urea was added to Ringer's
containing 2 mtvt cold urea bathing the mucosal surface of the
hemibladders. Samples of the serosal and mucosal bath were
then taken for counting every 30 mm for a 1-hr control period.
Vasopressin, 40 or 1 mU/mi, was then added to the serosal
bathing medium. Samples of both mucosal and serosal bathing
solutions were taken for counting every 15 mm following
vasopressin exposure for a total of 1 hr. The samples were then
counted in a liquid scintillation spectrometer (Searle Analytical
Mark III, Chicago, Illinois, USA) for 10 mm to achieve a
counting rate 1,000 times above background. In initial experi-
ments, Ringer's containing bilirubin was present on the serosal
side with mucosal to serosal urea flux observed. Similar urea
fluxes were measured with bilirubin in the mucosal bath.
Lastly, the back flux of urea (serosal to mucosal) was deter-
mined with both bilirubin and urea present in the serosal
medium. As previously mentioned, the chambers were covered
to prevent breakdown of bilirubin caused by light exposure.
The permeability coefficient, Ktrans, for urea was then calcu-
lated according to the formula below:
number of counts on the labeled side
)< membrane area x time (2)
Membrane area = 3.06 cm2
31P NMR analysis
31P nuclear magnetic resonance analysis of the tissues was
undertaken to assess qualitative changes in intracellular high
energy phosphate compounds in the presence and absence of
bilirubin. Hemibladders from three toads were incubated in
amphibian Ringer's containing 0.05% BSA and bilirubin 0.1 mM
scct
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Fig. 1. Effect of bilirubin on vasopressin-stimulated short Circuit current
(SCC). While bilirubin 0.1 m had no effect on basal SCC (control 58.1
6.0 pAmps vs. BR 49.3 7.5 Amps), the peak response to
vasopressin was inhibited by 18 6% (control-VP 143.9 15.3 Amps
vs. BR-VP 99.3 14.1 Amps) (N = 10; P < 0.02).
for 45 mm. Vasopressin, 40 mU/ml, was then added to the bath
and the incubation was continued for an additional 30 mm. The
tissues were then transferred into a 10 mm NMR tube cooled to
4°C containing Ringer's with 0.05% BSA, bilirubin, and vaso-
pressin. NMR spectra were obtained on the sample over the
next 30 mm at 4°C following the method of Bond et al [111. The
procedure was repeated with the matched control hemiblad-
ders; bilirubin was absent from the bath.
The scans were generated using a Fournier transform nuclear
magnetic resonance spectrometer (Bruker WM 250 Bruker
Instruments, Billerica, Massachusetts, USA) with an operating
frequency of 101.3 MHz for 31P. A 90° pulse with a recycle time
of 1.5 sec was used in these studies. The Ringer's in the NMR
tubes was made up with 20% D20 for a field-frequency lock.
Spectra were processed with a line broadening of 50 Hz.
Results
Effect of bilirubin on sodium transport
Bilirubin in the serosal bathing medium appeared to have no
effect on basal SCC and PD during a 45-mm observation period.
With vasopressin stimulation, the peak SCC response in
bilirubin-exposed bladders was 18 6% less than in matched
controls (P < 0.02; N = 10; Fig. 1). When this experiment was
repeated with 0.5% rather than 0.05% BSA and bilirubin in the
serosal medium, the inhibitory effects of bilirubin on SCC
disappeared. Moreover, bilirubin and 0.05% BSA in the
mucosal bath had no effect on basal or vasopressin-stimulated
SCC.
Since vasopressin action is mediated in the epithelial cell
through the generation of cyclic AMP, the effect of bilirubin on
cyclic AMP-stimulated sodium transport was next examined.
As before, bilirubin in the serosal medium did not affect basal
SCC or PD. Following stimulation with the cyclic AMP analog,
iO M, the peak rise in SCC was inhibited by 24 5% (P <
0.01; N = 11; Fig. 2), a response similar to that seen earlier with
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• — Experimental
Means SEM
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1. P<0.05
° P'<0.02
$ $
BR VP
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Fig. 2. Effect of bilirubin on cyclic AMP-stimulated short circuit current(SCC). Basal SCC was unaffected by bilirubin (control 49.5 9.7
Amps vs. BR 52.2 7.1 Amps). Bilirubin inhibited the peak
response to cyclic AMP (l0- M) by 24 5% (control cyclic AMP 120.6
18.8 pAmps vs. BR-cAMP 99.5 11.1 Amps)(N = ll;P<0.0l).
The inhibition could be abolished with cyclic AMP (I0- M).
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Fig. 3. Effect of bilirubin on aldosterone-stimulated short circuit current(SCC). The aldosterone-stimulated increase in SCC was unaffected by
bilirubin over the entire 360 mm of the study.
the vasopressin. A supramaximal dose of cyclic AMP, iO M,
overcame the effects of bilirubin.
Aldosterone also stimulates sodium transport in the toad
urinary bladder, but the transport depends on protein synthesis
[121. Thirty to ninety minutes may elapse before an increase in
SCC is observed. After a 45-mm exposure to bilirubin, aldo-
sterone was added to both experimental and control bladders.
In six pairs of experiments. bilirubin appeared to have no
influence on aldosterone-stimulated SCC over the 360-mm
observation period (Fig. 3).
The effect of bilirubin on the sodium pump was indirectly
tested when the mucosal surfaces of the hemibladders were
incubated with the standard amphibian Ringer's solution con-
taining amphotericin B (2.5 pJml). Amphotericin B, an
antifungal agent, alters the mucosal barrier to sodium entry
resulting in a transient increase in sodium transport, reflected
—60 —30 0 30 60 90 120
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Fig. 4. Effect of biliruhin on amphotericin B-stimulated short circuit
current (SCC). Bilirubin in the serosal bath did not influence the
increase in SCC produced by amphotericin B (2.5 g/ml) in the mucosal
bath.
by a rise in SCC [13]. As before, basal SCC was unaffected by
bilirubin in the serosal bath. Incubation with amphotericin B
caused a similar increase in both control and bilirubin-exposed
bladders (N = 6; Fig. 4).
Effect of bilirubin on the hydro-osmotic response to
vasopressin and cyclic AMP
A 30-mm incubation with bilirubin in the serosal bath had no
effect on basal water movement. When vasopressin (20 mU/mI)
was added to the serosal bath, no significant difference in the
hydro-osmotic response to the hormone was noted. Mean water
flow for control tissues was 46.5 2.7 mg/mm, while experi-
mental bladders demonstrated water flow of 45.5 3.3 mglmin
(N = 9). Similar results were seen with vasopressin I mU/ml;
control 41.0 5.3 mg/mm versus experimental 44.9 mg/mm, N
= 6. When tissues were stimulated with the cyclic AMP analog
at l0— M, the hydro-osmotic response was again not affected
by the presence of bilirubin in the serosal bathing medium. Peak
water flow in control tissue averaged 24.2 3.5 mg/mm, while
experimental tissues demonstrated water flow of 21.0 2.9
mg/mm (N = 6).
Effect of bilirubin on urea permeability
Bilirubin in the serosal bathing medium did not appear to
influence the basal mucosal to serosal flux of urea as reflected
by the urea permeability coefficient, Ktrans. When the bladders
were stimulated with vasopressin, I or 40 mU/ml, Ktrans for urea
increased tenfold in both control and experimental tissues and
was unaffected by the bilirubin. When the experiment was
repeated with bilirubin and urea present in the mucosal bathing
medium, no statistical difference in basal or vasopressin-stim-
ulated Ktrans was seen (Table 1). Lastly, bilirubin in the serosal
bath did not influence vasopressin (40 mU/ml) stimulated
serosal to mucosal backflux of urea (Ktrans control 62.3 6.1 x
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Table 1. Urea permeability (Ktrans) in the presence of bilirubin (0.1 mM)a
Group
Urea x i0 cm2/sec SEM
Basal N
Vasopressin
40 mU/mi N Basal N Vasopressin1 mU/mi N
Bilirubin serosal bath
Control
Experimental
6.7 1.8
6.6 2.0
8
8
76.3 4.6 12
72.2 4.2 12
3.0 0.7
3.9 0.7
8
8
78.0 9.2
75.0 8.9
16
16
Bilirubin mucosal bath
Control
Experimental
2.6 0.3
2.2 0.4
7
7
70.4 5.1 10
65.8 5.2 10
2.3 0.3
2.3 0.8
5
5
71.0 7.2
68.0 6.7
16
16
a Mucosal-to-serosal fluxes of '4C urea were measured in the basal and vasopressin-stimulated state (40 and 1 mU/ml).
a-ATP
(Experimental - Control)
Fig. 5. -'P NMR analysis. The presence of bilirubin had no demon-
strable effect on any of the high energy phosphate peaks. When control
spectra (dashed line) were subtracted from experimental spectra (solid
line) a signal indistinguishable from background noise resulted. Each
peak is labeled: SP, sugar phosphates; P,, inorganic phosphate; PDE,
phosphodiesters; PCr, creatine phosphate; yATP, yATP + I3ADP;
aATP, nATP + sADP; and I3ATP = /3ATP.
l0— cm2/sec VS. Ktrans experimental 62.5 8,1 x iO cm2!
see; N = 6).
31P NMR analysis
Spectra from two separate experiments averaging 1200 scans
each were pooled for both experimental and control tissues
depicted in Figure 5. No significant differences in the high
energy phosphate peaks were observed in hemibladders ex-
posed to bilirubin as compared to controls. Subtraction of the
pooled experimental spectra from the pooled control spectra
revealed a signal indistinguishable from background noise. The
creatine phosphate to y ATP ratio in both sets of spectra was
0.5, a ratio similar to 0.6 0.1 reported by Bond et al [11] in the
toad urinary bladder. The times of tissue exposure to bilirubin
and bilirubin with vasopressin paralleled the previously de-
scribed incubation periods when bilirubin inhibited vasopressin-
stimulated SCC.
Discussion
Bilirubin nephropathy in homozygous Gunn rats has been
characterized by urinary concentrating defects, increased so-
dium wasting, and a decreased cortical medullary sodium
concentration gradient, all associated with crystalline bilirubin
in the renal medulla [1—3]. Gunn weanling rats demonstrate
many of these changes by 21 days of age [31. Moreover, these
animals have lower concentrations of urea and sodium in the
renal medulla compared to control heterozygous or light-treated
homozygous litter mates [31. From these and other observa-
tions, Martinez-Maldonado, Suki, and Schenker [2] suggested
that the defects in urinary concentrating ability are directly
related to unconjugated bilirubin impairing solute and/or water
transport in the loop of Henle. Sodium and urea are the major
solutes which account for the maintenance of renal medullary
hypertonicity [14]. Thus, bilirubin-related diminished transport
of either or both of these solutes could possibly influence the
ability of the kidney to concentrate or dilute urine. In addition,
the hydro-osmotic response to vasopressin in renal collecting
ducts may be directly influenced by bilirubin. The present
studies, conducted with the toad urinary bladder, examined the
effect of bilirubin on the transepithelial transport of these
solutes and water.
Short-term exposure to bilirubin in the concentration tested
appeared to have no direct effect on basal SCC or PD. Bilirubin
in the serosal bath resulted in a significant inhibition in
vasopressin-stimulated SCC. The inhibitory effects of bilirubin
were observed only with bilirubin on the serosal or blood side of
the epithelial membrane and could be eliminated by increasing
the albumin in the serosal bath to 0.5%. This is consistent with
the increased binding of bilirubin to albumin, thereby prevent-
ing bilirubin interaction with the epithelial cell.
Vasopressin action is mediated in the cell by cyclic AMP
through stimulation of adenylate cyclase, an enzyme located at
or near the serosal membrane [151. The inhibitory effect of
bilirubin on vasopressin-stimulated SCC could be related in part
to an alteration in the vasopressin membrane receptor or an
effect on the enzyme, adenylate cyclase. Bilirubin has been
shown to inhibit adenylate cyclase isolated from fat cells [16].
In our experiments, bilirubin also inhibited cyclic AMP (lO—
M) stimulated SCC. Thus, alterations proximal to the generation
of cyclic AMP, for example, in the membrane receptor or in
adenylate cyclase, seem to be unlikely explanations for the
diminished SCC response. The observed effects of bilirubin on
vasopressin and cyclic AMP (lOs M) stimulated SCC would be
consistent with a selective bilirubin-induced inhibition of a
specific cyclic AMP-dependent protein kinase. Diminished cy-
clic AMP-dependent protein kinase activity has been described
in rabbit brain, and the bilirubin-induced change in enzyme
activity was partially or completely restored with the
phosphodiesterase inhibitor, aminophylline [17]. Like
'y-ATP
PCr
PDE
Pi
sP
P-ATP
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aminophylline, the higher concentration of cyclic AMP (10—a
M) in our experiments may have overcome the effect of bilirubin
on this enzyme.
Aldosterone also stimulates sodium transport in the toad
urinary bladder, but it does so by a mechanism independent of
cyclic AMP generation [12]. Bilirubin appeared to have no
major effect on the entry of aldosterone into the cells or on the
intracellular apparatus associated with sodium transport.
Amphotericin B indirectly tests the integrity of the serosal
membrane sodium pump [13]. Here, as with aldosterone,
bilirubin (0.1 mM) had no effect on the increased Na-K ATPase
pump activity induced by the rise in cytosolic sodium. Although
Na-K ATPase isolated from human red blood cells [18] and rat
brain [191 can be inhibited by similar concentrations of
bilirubin, the effect is temperature-dependent, becoming appar-
ent when the temperature falls below 20°C. Since the present
experiments were conducted at 25°C, the expected inhibition of
NA-K ATPase would be minimal, beyond the sensitivity of this
bioassay.
Collectively taken, these data lead one to suggest that the
serosal sodium exit step is not the site of inhibition to
vasopressin-stimulated sodium transport. Because bilirubin did
not inhibit aldosterone, cyclic AMP at lO M, or amphotericin
B-stimulated sodium transport, it seems unlikely that the inhibi-
tory effects on vasopressin-stimulated SCC are the result of a
nonspecific alteration in the oxidative metabolism necessary for
active sodium transport [121. Although it represents a qualita-
tive analysis, the 31P NMR spectra, obtained when the inhibi-
tion of vasopressin-stimulated SCC was known to occur, dem-
onstrated no alteration in the ATP or Pi peaks in the presence of
bilirubin. This observation would also go against a generalized
suppression of oxidation metabolism and an inhibition of Na-K
ATPase due to decreased availability of ATP. The inhibitory
effect of bilirubin on vasopressin-stimulated SCC appears to be
at a site following the generation of cyclic AMP and could well
involve vasopressin-induced changes in mucosal membrane
sodium conductance.
In contrast to the SCC studies, the hydro-osmotic response to
vasopressin and cyclic AMP was unaffected by the presence of
bilirubin in the serosal bath. Vasopressin interacts with its
specific serosal membrane receptor, activating adenylate cy-
clase to produce cyclic AMP. A cascade of intracellular events
then occur which result in alterations in the apical or mucosal
membrane of the epithelial cell and allow for passive
transmembrane water movement along an osmotic gradient
[15]. The fact that bilirubin does not interfere with this process
further indicates that the vasopressin membrane receptor is
unaffected by bilirubin.
A decrease in the mucosal-to-serosal flux of urea could
conceivably lower medullary interstitial osmolality, resulting in
impaired countercurrent tubular transport of water and possibly
of sodium. In the present studies, bilirubin in the serosal
medium appeared to have no effect on basal urea flux. Bilirubin
induced a small, but statistically insignificant decrease in urea
permeability after stimulation with vasopressin. The major
barrier, however, to urea transport lies in the apical membrane
of the epithelial cell [10J. Since bilirubin has been shown to bind
to biologic membranes and possibly alter their function,
bilirubin was placed in the mucosal bathing solution and
mucosal-to-serosal urea flux was measured. Under these cir-
cumstances, bilirubin again produced no significant effect on
urea permeability, either in the basal or vasopressin-stimulated
state. Lastly, bilirubin in the serosal bath had no effect on
serosal to mucosal flux of urea in the vasopressin (40 mU/mi)
stimulated state. Bilirubin did not influence urea fluxes induced
by a lower concentration of vasopressin (1 mU/mi). In contrast
to the studies of Carvounis et a! [20], tissue stimulation with
vasopressin, 1 mU/mi, was associated with near maximal urea
fluxes and water movement. No separation in the transport of
these two substances could be demonstrated with or without
bilirubin at this lower concentration of vasopressin. Taken
together, these data indicate that the increase in urea perme-
ability induced by vasopressin is not affected by short-term
exposure to bilirubin. The possibility that prolonged exposure
to bilirubin may have an inhibitory effect on urea transport,
cannot be excluded from the present data. Such a possibility
may, in fact, account for the decrease in renal medullary urea
concentrations found in the Gunn strain of rat.
Short-term exposure to bilirubin produces a limited inhibitory
effect on vasopressin-stimulated active sodium transport but
does not influence the membrane permeability changes allowing
for passive urea and water transepithelial movement, These
findings may help explain the apparently conflicting observa-
tions in the hyperbilirubinemic newborn infant. In the newborn,
alterations in renal function were only observed under condi-
tions where the infant was challenged with a volume and salt
load. Since the infants were hyperbilirubinemic for very limited
periods of time, the picture of bilirubin nephropathy, as de-
scribed in the hyperbilirubinemic Gunn rat, never fully developed.
Acknowledgments
This material was presented in part at the Society of Pediatric
Research meeting, Washington, D.C., April 1982. The authors thank
Mrs. C. McGloin for secretarial assistance. NMR Spectra were obtained
using a spectrometer purchased with funds from Montedison S.p.A.
and the National Science Foundation.
Reprint requests to Dr. A. S. Brein, Division of Pediatric Nephrol-
ogy, Rhode Island Hospital, 593 Eddy Street, Providence, Rhode
Island 02902, USA
References
1. ODEL1. GB, NATZSCFIKA JC, STOREY GNB: Bilirubin nephropathy
in the Gunn strain of rat. Am J Physiol 212:931—938, 1967
2. MARTINEZ-MALDONADO M, SUKI WN, SCHENKER S: Nature of the
urinary concentrating defect in the Gunn strain of rat. Am J Physiol
216:1386—1391, 1969
3. CALL NB, TI5HER CC: The urinary concentrating defect in the
Gunn strain of rat. J C/in Invest 55:319—329, 1975
4. WHITINGTON PF, OLSEN WA, ODELL GB: The effect of bilirubin
on the function of hamster small intestine. Pediatr Res
15:1009—1014, 1981
5. BROBERGER U, APERIA A: Renal function in infants with hy-
perbilirubinemia. Acta Paediatr Scand 68:75—79, 1979
6. ENGLE WD, ARANT BS: Neonatal hyperbilirubinemia and renal
function. J Pediatr 100:113—1 16, 1982
7. LEAF A: On the functional structure of the transport system in the
toad bladder, in Proc 3rd mt Congr Nephrol, edited by SCHREINER
G, Base!, New York, Karger, 1967, vol 3, pp 18—26
8. UssiNo HH, ZERAHN K: Active transport of sodium as the source
of electric current in the short-circuited isolated frog skin. Acta
Physiol Scand 23:110—127, 1951
9. BENTLEY PJ: The effects of neurohypophyseal extracts on water
Brem et al
transfer across the wall of the isolated urinary bladder of the toad
Bufo marinus. J Endocrinol 17:201—209, 1958
10. MAFFLY RH, HAYS RM, LAMDIN E, LEAF A: The effect of
neurohypophyseal hormones on the permeability of the toad blad-
der to urea. J Gun Invest 36:630—641, 1960
11. BOND M, SI-IPORER M, PETERSON K, CIVAN MM: 31P nuclear
magnetic resonance analysis of toad urinary bladder. Mol Physiol
1:243—263, 1981
12. MACKNIGHT ADC, DIBONA DR, LEAF A: Sodium transport across
the toad urinary bladder: A model "tight" epithelium. Physiol Rev
60:615—715, 1980
13. LICHTENSTEIN NS, LEAF A: Effect of amphotericin B on the
permeability of the toad bladder. J Gun Invest 44:1328—1342, 1965
14. JAMISON RL, MAFFLY RH: The urinary concentrating mechanism.
N Engi J Med 295:1059—1067, 1976
15. HAYS R: Antidiuretic hormone. N Engl J Med 295:659—665, 1976
57
16. SHEPHERD RE, MORENO FJ, CASHORE Wi, FAIN iN: Effects of
bilirubin on fat cell metabolism and lipolysis. Am J Physiol
237:E504—E508, 1979
17. MORPHIS L, CONSTANTOPOULOS A, MATSANIOTIS N, PAPAPHILIS
A: Bilirubin-induced modulation of cerebral protein phosphoryl-
ation in neonate rabbits in vivo. Science 218:156—158, 1982
18. KAWAI K, COWGER ML: Effect of bilirubin on ATPase activity of
human erythrocyte membranes. Res Commun Chem Pathol
Pharmacol 32:123—135, 1981
19. KASHIWAMATA S, AsAI M, SEMBA RK: Effect of bilirubin on the
Arrhenius plots for Na-K-ATPase activities of young and adult rat
cerebra. J Neurochem 36:826—829, 1981
20. CARvouNis CP, FRANKI N, LEVINE SD, HAYS RM: Membrane
pathways for water and solutes in the toad bladder. I. Independent
activation of water and urea transport. J Membr Biol 49:253—268,
1979
